21.59 USD
+0.96 (+4.65%)
We assign a fundamental rating of 2 out of 10 to ATEC. ATEC was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ATEC may be in some trouble as it scores bad on both profitability and health. ATEC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ATEC has reported negative net income.
ATEC had a negative operating cash flow in the past year.
In the past 5 years ATEC always reported negative net income.
ATEC had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -19.68%, ATEC perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of -441.37%, ATEC is doing worse than 81.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.68% | ||
| ROE | -441.37% | ||
| ROIC | N/A |
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 69.23%, ATEC is doing good in the industry, outperforming 75.53% of the companies in the same industry.
In the last couple of years the Gross Margin of ATEC has remained more or less at the same level.
ATEC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ATEC has more shares outstanding
Compared to 1 year ago, ATEC has a worse debt to assets ratio.
2.2 Solvency
ATEC has an Altman-Z score of 0.89. This is a bad value and indicates that ATEC is not financially healthy and even has some risk of bankruptcy.
ATEC has a Altman-Z score of 0.89. This is comparable to the rest of the industry: ATEC outperforms 51.06% of its industry peers.
ATEC has a Debt/Equity ratio of 14.10. This is a high value indicating a heavy dependency on external financing.
ATEC has a Debt to Equity ratio of 14.10. This is amonst the worse of the industry: ATEC underperforms 88.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 14.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.89 |
ROIC/WACCN/A
WACC7.83%
2.3 Liquidity
ATEC has a Current Ratio of 1.99. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
ATEC's Current ratio of 1.99 is on the low side compared to the rest of the industry. ATEC is outperformed by 64.89% of its industry peers.
ATEC has a Quick Ratio of 1.24. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
ATEC's Quick ratio of 1.24 is on the low side compared to the rest of the industry. ATEC is outperformed by 68.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
ATEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.34%, which is quite impressive.
ATEC shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.11%.
Measured over the past years, ATEC shows a very strong growth in Revenue. The Revenue has been growing by 40.08% on average per year.
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.14%
Revenue 1Y (TTM)27.11%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%30.38%
3.2 Future
Based on estimates for the next years, ATEC will show a very strong growth in Earnings Per Share. The EPS will grow by 29.11% on average per year.
Based on estimates for the next years, ATEC will show a quite strong growth in Revenue. The Revenue will grow by 16.90% on average per year.
EPS Next Y19.18%
EPS Next 2Y27.23%
EPS Next 3Y26.77%
EPS Next 5Y29.11%
Revenue Next Year24.39%
Revenue Next 2Y19.97%
Revenue Next 3Y19.36%
Revenue Next 5Y16.9%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
ATEC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ATEC indicates a somewhat cheap valuation: ATEC is cheaper than 61.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2506.72 |
4.3 Compensation for Growth
ATEC's earnings are expected to grow with 26.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.23%
EPS Next 3Y26.77%
5. Dividend
5.1 Amount
No dividends for ATEC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ATEC (11/25/2025, 2:37:57 PM)
21.59
+0.96 (+4.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners69.39%
Inst Owner Change6.51%
Ins Owners8.98%
Ins Owner Change-3.12%
Market Cap3.19B
Revenue(TTM)728.02M
Net Income(TTM)-154.96M
Analysts82.22
Price Target24.23 (12.23%)
Short Float %11.37%
Short Ratio5.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.25%
Min EPS beat(2)-33.22%
Max EPS beat(2)16.71%
EPS beat(4)1
Avg EPS beat(4)-19.45%
Min EPS beat(4)-45.93%
Max EPS beat(4)16.71%
EPS beat(8)1
Avg EPS beat(8)-17.69%
EPS beat(12)1
Avg EPS beat(12)-21.02%
EPS beat(16)1
Avg EPS beat(16)-22.1%
Revenue beat(2)2
Avg Revenue beat(2)3.61%
Min Revenue beat(2)1.74%
Max Revenue beat(2)5.49%
Revenue beat(4)3
Avg Revenue beat(4)1.58%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)5.49%
Revenue beat(8)6
Avg Revenue beat(8)1.25%
Revenue beat(12)10
Avg Revenue beat(12)1.81%
Revenue beat(16)14
Avg Revenue beat(16)2.76%
PT rev (1m)22.37%
PT rev (3m)25.3%
EPS NQ rev (1m)-5.45%
EPS NQ rev (3m)-529.63%
EPS NY rev (1m)-0.82%
EPS NY rev (3m)-2.07%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)1.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.39 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 2506.72 |
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.92
BVpS0.24
TBVpS-0.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.68% | ||
| ROE | -441.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.23% | ||
| FCFM | N/A |
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
F-Score4
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 14.1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 358.97 | ||
| Cap/Depr | 51.3% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.99 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 0.89 |
F-Score4
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)138.42%
Cap/Depr(5y)170.73%
Cap/Sales(3y)16.62%
Cap/Sales(5y)18.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.14%
EPS Next Y19.18%
EPS Next 2Y27.23%
EPS Next 3Y26.77%
EPS Next 5Y29.11%
Revenue 1Y (TTM)27.11%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%30.38%
Revenue Next Year24.39%
Revenue Next 2Y19.97%
Revenue Next 3Y19.36%
Revenue Next 5Y16.9%
EBIT growth 1Y46.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.78%
EBIT Next 3Y91.37%
EBIT Next 5Y70.18%
FCF growth 1Y71.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.87%
OCF growth 3YN/A
OCF growth 5YN/A
ALPHATEC HOLDINGS INC / ATEC FAQ
What is the fundamental rating for ATEC stock?
ChartMill assigns a fundamental rating of 2 / 10 to ATEC.
What is the valuation status for ATEC stock?
ChartMill assigns a valuation rating of 1 / 10 to ALPHATEC HOLDINGS INC (ATEC). This can be considered as Overvalued.
What is the profitability of ATEC stock?
ALPHATEC HOLDINGS INC (ATEC) has a profitability rating of 1 / 10.
Can you provide the financial health for ATEC stock?
The financial health rating of ALPHATEC HOLDINGS INC (ATEC) is 1 / 10.